Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Research Site, Oxford, United Kingdom
Hammersmith Medicines Research, London, United Kingdom
Research Site, Leeds, United Kingdom
Research Site, Cambridge, Massachusetts, United States
Research Site, Dallas, Texas, United States
The Research Center of Southern California, Carlsbad, California, United States
Karolinska Universitetssjukhuset, Huddinge, Stockholm, Sweden
Ospedale San Raffaele, Milano, Italy
Research Site, Göttingen, Germany
CHU Nice - Hôpital de l'Archet 1, Nice, France
Nemocnice Pardubickeho kraje a.s. Pardubicka nemocnice, Pardubice, Czechia
Diabetologische Schwerpunktpraxis Harburg, Hamburg, Germany
Research Site, Ulm, Germany
Research Site, Daytona Beach, Florida, United States
Royal Hallamshire Hospital, Sheffield, West Midlands, United Kingdom
University of Kansas Medical Center Research Institute, Kansas City, Kansas, United States
Cedars Sinai, Los Angeles, California, United States